Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Change in Cash (2018 - 2025)

Viemed Healthcare's Change in Cash history spans 8 years, with the latest figure at $2.4 million for Q4 2025.

  • For Q4 2025, Change in Cash fell 61.6% year-over-year to $2.4 million; the TTM value through Dec 2025 reached -$4.0 million, down 185.92%, while the annual FY2025 figure was -$4.0 million, 185.92% down from the prior year.
  • Change in Cash reached $2.4 million in Q4 2025 per VMD's latest filing, up from -$8.9 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $9.9 million in Q2 2025 to a low of -$13.3 million in Q2 2023.
  • Average Change in Cash over 5 years is -$874000.0, with a median of $85000.0 recorded in 2021.
  • Peak YoY movement for Change in Cash: tumbled 13666.67% in 2022, then surged 1839.73% in 2024.
  • A 5-year view of Change in Cash shows it stood at $1.5 million in 2021, then plummeted by 396.17% to -$4.6 million in 2022, then soared by 160.5% to $2.8 million in 2023, then skyrocketed by 124.3% to $6.2 million in 2024, then tumbled by 61.6% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Change in Cash are $2.4 million (Q4 2025), -$8.9 million (Q3 2025), and $9.9 million (Q2 2025).